Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
4.550
-0.510 (-10.08%)
Nov 5, 2026, 4:00 PM EST - Market closed
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $164.06 million as of November 5, 2026. It is the 21,644th most valuable company in the world and the 3,679th biggest in the United States. Its market cap has decreased by 30.29% in one year.
Market Cap
164.06M
Enterprise Value
18.36M
1-Year Change
-30.29%
Global Rank
Country Rank
#3,679 United States
Category
ChartMarket Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has decreased from $251.01M to $164.06M, a decrease of -34.64%. That is a compound annual growth rate of -8.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 164.06M | -55.50% |
| Dec 31, 2025 | 368.66M | -39.78% |
| Dec 31, 2024 | 612.16M | 21.70% |
| Dec 29, 2023 | 503.01M | 18.72% |
| Dec 30, 2022 | 423.70M | -20.71% |
| Dec 31, 2021 | 534.36M | 112.88% |
| Oct 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compugen | 192.29M |
| ALX Oncology Holdings | 188.06M |
| Invivyd | 186.76M |
| Alpha Cognition | 185.77M |
| BridgeBio Oncology Therapeutics | 184.40M |
| MediWound | 183.33M |
| Whitehawk Therapeutics | 180.72M |
| Canton Strategic Holdings | 172.11M |